At this time, posts about Samsung Pharmaceutical are rapidly increasing on portals and securities communities, while foreign investors are tentatively estimated to have net sold 2,000 shares today. Samsung Pharmaceutical is known as a leading pharmaceutical company specializing in over-the-counter drugs such as Gas Myeong-su.


As of 1:30 PM on the 5th, Samsung Pharmaceutical's stock price rose 29.98% from the previous day to 8,280 KRW, with a trading volume of 4,835,678 shares, which is about 16.97% of the average trading volume on the 5th. On December 29th, Samsung Pharmaceutical was a market issue due to the "completion of Phase 3 trial for pancreatic cancer treatment," which caused a strong rally.


In addition to Samsung Pharmaceutical, posts by investors are also rapidly increasing for ST Pharm (237690), Anam Electronics (008700), and Wizit (036090).



※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing